Treatments and Therapies Topics InformationAdviceNewsReal storiesResearchSupport usDementia directory
Research Understanding the effects of the diabetes type 2 drug Metformin on models of Alzheimer’s disease Research project: Metformin in Alzheimer’s disease
Research Can artificial intelligence help us to understand and treat dementia? A new artificial intelligence programme, AlphaFold 2, has been described as a breakthrough in the ‘protein folding’ problem. Researchers Dr Karen Marshall and Prof Louise Serpell explain what this means for dementia research. 02 February 2021 1
Research Using the cell’s internal machinery to break down protein plaques in dementia Research projects: Isolation of cell-intrinsic protein aggregation handling machinery
News Positive drug trial results of a new treatment for dementia-related psychosis presented at Clinical Trials on Alzheimer’s Disease conference - Alzheimer's Society comment Researchers presented results from a phase 3 trial of pimavanserin that showed a significant reduction in the risk of relapse into psychosis compared to the placebo.
News Alzheimer's Society responds to Biogen, Aducanumab results at Clinical Trials on Alzheimer's Disease Conference (CTAD) Biogen presented their results on Aducanumab, their newest drug for the treatment of Alzheimer's disease at the CTAD conference 2019 in San Diego, USA.
Research Investigating if peptide inhibitors can treat Alzheimer’s disease Research project title: Peptide inhibitors of Tau aggregation as a potential treatment for Alzheimer's disease
News Biogen Inc. will ask U.S. drug regulators to approve new Alzheimer’s drug, Alzheimer’s Society responds Biogen Inc. will ask U.S. drug regulators to approve the company’s experimental Alzheimer’s therapy, reviving the nearly abandoned treatment, after a new analysis of data from two failed clinical trials showed promising results.
News Biogen to halt late-stage trial of Alzheimer’s dug – Alzheimer’s Society comment US pharmaceuticals company Biogen and its Japanese partner Eisai have announced they will discontinue a global Phase 3 trial for a promising Alzheimer’s disease treatment, aducanumab.
Research Namaste care: research update Malayka Rahman-Amin, Research Translation Manager at Alzheimer's Society, tells us about a therapy for people with advanced dementia, and how her role supports researchers to make a real-world impact. 07 March 2019 0
Research Stem cells and Alzheimer's disease Sian Gregory, from our Will to Remember team, has a background with years of research into stem cells. Here Sian reports on some of the latest dementia research involving them. 05 March 2019 2
News Exercise-induced hormone may prevent memory loss New research, published in the Nature journal today, suggests there may be a relationship between the exercise-induced protein hormone irisin and the progression of Alzheimer's disease.
News Yale researchers say new compound shows promise in dementia treatment - Alzheimer's Society comment According to a new study, Yale University researchers have identified a drinkable cocktail of molecules that interferes with a first step of Alzheimer’s disease.
